Skip to content

Community-based Cohort Study of Cognitive Function in Older Adults with and without Diabetes

Community-based Cohort Study of Cognitive Function in Older Adults with and without Diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128863
Enrollment
Unknown
Registered
2026-07-27
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus, Cognitive impairment, Dementia

Interventions

Normal blood sugar control group:None

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Group A (Diabetic population) (1) Age> = 60 years, no gender restriction; (2) Meeting the World Health Organization (WHO) or American Diabetes Association (ADA) diagnostic criteria: fasting blood glucose >=7.0 mmol/L, or oral glucose tolerance test 2-hour blood glucose >=11.1 mmol/L, or glycated hemoglobin (HbA1c) >=6.5%, or a previously confirmed diagnosis of diabetes and currently receiving hypoglycemic treatment; (3) Have lived in Songjiang District for at least one year and expect to continue living there for the next 10 years; (4) Voluntarily participate and sign the informed consent form. 2. Group B (Normal blood glucose control) (1) Age> = 60 years, no gender restriction (age and gender frequency matching are used for diabetes groups); (2) Fasting blood glucose < 6.1 mmol/L, glycated hemoglobin <6%, no history of diabetes, and no use of any hypoglycemic drugs; (3) Have lived in Songjiang District for at least one year and expect to continue living there for the next 10 years; (4) Voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Group A (People with Diabetes) (1) Previously diagnosed with Alzheimer's disease or other types of dementia; (2) History of stroke, brain surgery, or brain injury; (3) Severe mental illnesses (such as schizophrenia or bipolar disorder); (4) Severe vision, hearing, or speech impairments that prevent cooperation with cognitive assessment; (5) Confirmed olfactory disorders (including rhinitis, moderate to severe asthma, nasopharyngeal tumors, nasal deformities, nasal surgery, etc.); (6) Terminal malignant tumors or other serious physical illnesses, with an expected lifespan of less than 2 years; (7) Currently participating in other clinical trials that may affect cognitive function. 2. Group B (Normal Blood Sugar Control Group) (1) People with prediabetes, including fasting blood glucose 6.1-7.0 mmol/L or HbA1c 6.0-6.5%; (2) All other exclusion criteria are the same as for the diabetes group.

Design outcomes

Primary

MeasureTime frame
Annual change in cognitive function score;

Secondary

MeasureTime frame
The incidence of mild cognitive impairment (MCI) or dementia;

Countries

China

Contacts

Public ContactFang Fang

Shanghai General Hospital

fangfangdr@yeah.net+86 21 63240090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026